Masimo Corp
NASDAQ:MASI
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
92.89
177.7
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Masimo Corp
Masimo Corp
Other Non-Cash Items
Masimo Corp
Other Non-Cash Items Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Other Non-Cash Items | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Masimo Corp
NASDAQ:MASI
|
Other Non-Cash Items
$44.7m
|
CAGR 3-Years
3%
|
CAGR 5-Years
4%
|
CAGR 10-Years
18%
|
|
|
Becton Dickinson and Co
NYSE:BDX
|
Other Non-Cash Items
-$46m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
9%
|
CAGR 10-Years
N/A
|
|
|
Boston Scientific Corp
NYSE:BSX
|
Other Non-Cash Items
$676m
|
CAGR 3-Years
322%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Stryker Corp
NYSE:SYK
|
Other Non-Cash Items
$313m
|
CAGR 3-Years
-25%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
-8%
|
|
|
Abbott Laboratories
NYSE:ABT
|
Other Non-Cash Items
$802m
|
CAGR 3-Years
-9%
|
CAGR 5-Years
0%
|
CAGR 10-Years
12%
|
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Other Non-Cash Items
$604.6m
|
CAGR 3-Years
11%
|
CAGR 5-Years
14%
|
CAGR 10-Years
12%
|
|
Masimo Corp
Glance View
Masimo Corp. is a pioneering medical technology company that specializes in innovative non-invasive monitoring solutions. Founded in 1989 and headquartered in Irvine, California, Masimo revolutionized the field of patient monitoring with its groundbreaking pulse oximetry technology, which provides accurate blood oxygen saturation levels in a wide range of settings, from hospitals to home care. The company has continued to expand its product portfolio, introducing advanced monitoring solutions that measure multiple physiological parameters critical for patient care. With a strong emphasis on research and development, Masimo maintains a competitive edge, driving both innovation and customer loyalty across the global healthcare market. For investors, Masimo presents a compelling growth story. As the demand for effective remote patient monitoring rises, driven by trends in telehealth and an aging population, the company is well-positioned to capitalize on these opportunities. Masimo's focus on integrating sophisticated technologies, such as measure-through motion and low perfusion capabilities, sets it apart from traditional monitoring devices. Moreover, with a solid financial foundation and a history of steady revenue growth, Masimo continues to demonstrate resilience in the face of market challenges. This combination of innovation, market demand, and financial stability makes Masimo Corp. an intriguing option for investors looking to tap into the evolving landscape of healthcare technology.
See Also
What is Masimo Corp's Other Non-Cash Items?
Other Non-Cash Items
44.7m
USD
Based on the financial report for Sep 28, 2024, Masimo Corp's Other Non-Cash Items amounts to 44.7m USD.
What is Masimo Corp's Other Non-Cash Items growth rate?
Other Non-Cash Items CAGR 10Y
18%
Over the last year, the Other Non-Cash Items growth was 204%. The average annual Other Non-Cash Items growth rates for Masimo Corp have been 3% over the past three years , 4% over the past five years , and 18% over the past ten years .
You don't have any saved screeners yet
